Sturm, Ruger & Company (RGR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
9 Mar, 2026Executive summary
Beretta Holding S.A. has nominated four candidates for election to the board at the 2026 annual meeting, seeking significant influence over governance and operations.
Beretta accumulated a 7.7% stake without prior engagement and demanded discounted shares, disproportionate board representation, and governance rights.
Ruger’s board adopted a short-term stockholder rights plan to protect against a creeping takeover and rejected Beretta’s demands as inconsistent with best practices and legal requirements.
Multiple meetings between the parties failed to resolve differences, with Beretta threatening a proxy contest if demands were not met.
Ruger remains committed to protecting all stakeholders and maintaining independence as a public company.
Voting matters and shareholder proposals
Beretta has formally notified its intent to nominate four directors at the 2026 annual meeting, including one affiliated with a Beretta subsidiary.
The board is reviewing Beretta’s notice in accordance with established procedures and applicable law.
Ruger will file a proxy statement and solicit proxies using a CAMO GREEN proxy card.
Board of directors and corporate governance
Three new directors were appointed in February 2026, following the retirement of three members, as part of a board refreshment process initiated before Beretta’s investment.
Five directors have joined the board in the past year, reflecting a proactive approach to governance and strategic focus.
The board’s refreshment process was delayed in good faith to facilitate negotiations with Beretta.
Criticism of board tenure by Beretta is contrasted with Beretta’s own long-serving directors.
Latest events from Sturm, Ruger & Company
- Board refresh and Ruger 2030 strategy drive strong returns and disciplined growth.RGR
Proxy filing24 Mar 2026 - Ruger’s board rebuffed Beretta’s control efforts, reinforcing governance and shareholder protections.RGR
Proxy Filing10 Mar 2026 - Board composition refreshed with new independent directors amid shareholder proposals.RGR
Proxy Filing3 Mar 2026 - Sales growth and innovation offset market declines, but profitability fell year-over-year.RGR
Q4 20252 Mar 2026 - Q2 sales and profit declined, but new products and efficiency gains support future growth.RGR
Q2 20242 Feb 2026 - Q3 2024 sales rose 1.2% to $122.3M, but EPS and net income declined on margin pressure.RGR
Q3 202417 Jan 2026 - Net income up 9.7% on flat sales, strong liquidity, and rising CapEx for innovation.RGR
Q1 202524 Dec 2025 - Q4 sales and earnings rebounded on new product strength and market share gains.RGR
Q4 202423 Dec 2025 - Board recommends director elections, auditor ratification, and executive pay policies for 2025.RGR
Proxy Filing1 Dec 2025